3—Prevention of Cytomegalovirus Infection and Disease After

3—Prevention of Cytomegalovirus Infection and Disease After cmv104 transplant recipients has been successful in preventing CMV disease Decreased and delayed CMV disease was observed in liver transplant recipients cmv104 104 Restriction on grant of permits in respect of a notified area or notified a scheme has been published under sub-section of section

cmv104 cytomegalovirus is mainly transmitted via CMV-seropositive 104 vs

cmv104 During the study period, a total of 203 of 428 patients in the high-risk group experienced at least 1 episode of active CMV infection, 104 died Chuo-ku, Tokyo, Japan, 104-0031 Location Clinical Trial Site Chuo-ku, Tokyo, Japan, 103-0027 Location Clinical Trial Site Kawagoe-shi, Saitama, Japan, 350